Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

被引:57
作者
Figlioli, Gisella [1 ]
Landi, Stefano [1 ]
Romei, Cristina [2 ]
Elisei, Rossella [2 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Endocrinol, I-56124 Pisa, Italy
关键词
Medullary thyroid carcinoma; RET gene mutations; RET gene polymorphisms; Meta-analysis; ENDOCRINE NEOPLASIA TYPE-2; CODON; 918; MUTATION; GERMLINE-SEQUENCE VARIANTS; TYROSINE KINASE ACTIVATION; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; MEN; 2A; MULTIVARIATE-ANALYSIS; DISEASE PHENOTYPE; CLINICOPATHOLOGICAL FEATURES;
D O I
10.1016/j.mrrev.2012.09.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Medullary thyroid carcinoma (MTC) is an uncommon malignant tumor arising from the calcitonin-producing parafollicular cells (C cells) of thyroid. It accounts for 5-10% of all thyroid cancers, and it mostly occurs as a sporadic entity (sMTC), but a familial pattern (fMTC) is also possible. RET protooncogene germline mutations are crucial for the onset and the progression of fMTC, and the occurrence of single nucleotide polymorphisms could predispose to the sporadic form. In order to clarify the role of this gene in MTC, we carefully reviewed the PubMed database using appropriate terms. First, we summarized current knowledge of the germline RET mutations, mutation spectrum, and prevalence. We then performed a meta-analysis on the available case-control association studies for sMTC. Finally, we carried out in silico predictions of the best associated variants in the attempt to better define their role in the disease. To date, a total of 39 different RET germline mutations have been identified in fMTC families. The most affected codons are 609, 611, 618, 620 (exon 10) and 634 (exon 11), encoding for the extracellular cysteine-rich domain, and codons 768 (exon 13) and 804 (exon 14) of the intracellular tyrosine kinase domain. Six polymorphisms with at least three studies were included in the meta-analysis (A45A [rs1800858], G691S [rs1799939], L769L [rs1800861 I, S836S [rs1800862], S904S [rs1800863], and IVS1-126G>T [rs2565206]). The meta-analysis demonstrated a modest association of sMTC susceptibility with S836S and a strong association with the IVS1-126G>T polymorphism. Besides RET polymorphisms, we also investigated the role of a few other low-penetrance alleles of genes involved in the RET pathway or in xenobiotic metabolism, but none of these were confirmed. Thus, despite the well-known molecular basis of fMTC, the genetic variants of the sporadic form are still poorly understood, and functional analyses are needed to better understand the consequence of such RET variants and to improve our knowledge on the disease. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 50 条
  • [1] Occurrence of sporadic medullary thyroid carcinoma in Graves' disease in association with a RET proto-oncogene mutation
    Donckier, Julian E.
    Fervaille, Caroline
    Bertrand, Claude
    ACTA CLINICA BELGICA, 2022, 77 (03) : 596 - 599
  • [2] A novel deletion in the RET proto-oncogene found in sporadic medullary thyroid carcinoma
    Alemi, M
    Lucas, SD
    Sallstrom, JF
    Akerstrom, G
    Wilander, E
    ANTICANCER RESEARCH, 1996, 16 (5A) : 2619 - 2622
  • [3] Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): Mutation analysis in Japanese patients with MTC
    Kitamura, Y
    Goodfellow, PJ
    Shimizu, K
    Nagahama, M
    Ito, K
    Kitagawa, W
    Akasu, H
    Takami, H
    Tanaka, S
    Wells, SA
    ONCOGENE, 1997, 14 (25) : 3103 - 3106
  • [4] Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC
    Yutaka Kitamura
    Paul J Goodfellow
    Kazuo Shimizu
    Mistuji Nagahama
    Kunihiko Ito
    Wataru Kitagawa
    Hiroki Akasu
    Hiroshi Takami
    Shigeo Tanaka
    Samuel A Wells Jr
    Oncogene, 1997, 14 : 3103 - 3106
  • [5] Somatic mutation of RET proto-oncogene in sporadic medullary thyroid carcinoma -: Report of a case and review of the literature
    Tsuru, Tsunehisa
    Usui, Takeshi
    Tsuji, Jun
    Minamiguchi, Sachiko
    Mori, Eisaku
    Hagiwara, Hanae
    Kimura, Takashi
    Tagami, Tetsuya
    Naruse, Mitsuhide
    Shimatsu, Akira
    ENDOCRINOLOGIST, 2008, 18 (02) : 55 - 59
  • [6] Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients
    A. Gursoy
    M. F. Erdogan
    G. Erdogan
    Journal of Endocrinological Investigation, 2006, 29 : 858 - 862
  • [7] Analysis of mutations of the RET proto-oncogene in patients with medullary thyroid carcinoma
    F. A. Amosenko
    V. Zh. Brzhezovskiy
    L. N. Lyubchenko
    M. A. Shabanov
    V. M. Kozlova
    V. E. Vanushko
    T. P. Kazubskaya
    R. F. Garkavtseva
    V. N. Kalinin
    Russian Journal of Genetics, 2003, 39 (6) : 706 - 711
  • [8] Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients
    Gursoy, A.
    Erdogan, M. F.
    Erdogan, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2006, 29 (10) : 858 - 862
  • [9] Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas
    Dvorakova, S.
    Vaclavikova, E.
    Sykorova, V.
    Vcelak, J.
    Novak, Z.
    Duskova, J.
    Ryska, A.
    Laco, J.
    Cap, J.
    Kodetova, D.
    Kodet, R.
    Krskova, L.
    Vlcek, P.
    Astl, J.
    Vesely, D.
    Bendlova, B.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 284 (1-2) : 21 - 27
  • [10] A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma:: a detection strategy
    Dang, GT
    Cote, GJ
    Schultz, PN
    Khorana, S
    Decker, RA
    Gagel, RF
    MOLECULAR AND CELLULAR PROBES, 1999, 13 (01) : 77 - 79